Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-331
Closed -$25K 2761
2026
Q1
$25K Buy
331
+129
+64% +$9.7K 0.01% 627
2025
Q4
$15K Buy
202
+127
+169% +$9.28K ﹤0.01% 710
2025
Q3
$5.06K Buy
75
+37
+97% +$2.46K ﹤0.01% 1077
2025
Q2
$2.48K Buy
38
+17
+81% +$1.02K ﹤0.01% 1093
2025
Q1
$1.3K Buy
21
+5
+31% +$331 ﹤0.01% 1169
2024
Q4
$1.15K Sell
16
-43
-73% -$3.36K ﹤0.01% 893
2024
Q3
$4.81K Sell
59
-11,517
-99% -$921K ﹤0.01% 560
2024
Q2
$860K Buy
11,576
+11,567
+128,522% +$867K 0.21% 60
2024
Q1
$702 Buy
9
+3
+50% +$223 ﹤0.01% 548
2023
Q4
$429 Sell
6
-9,889
-100% -$689K ﹤0.01% 504
2023
Q3
$687K Buy
9,895
+52
+0.5% +$3.93K 0.23% 89
2023
Q2
$797K Sell
9,843
-98
-1% -$8.01K 0.29% 63
2023
Q1
$802K Sell
9,941
-549
-5% -$44.2K 0.34% 60
2022
Q4
$785K Buy
+10,490
New +$747K 0.36% 54

Other funds holding HOLX

True Wealth Design's HOLX Position: Q2 2026 in Review

True Wealth Design sold out of Hologic (HOLX) in Q2 2026, closing a stake of 331 shares — an estimated $25K sold.

True Wealth Design first reported a position in HOLX in Q4 2022 and held it in 14 quarters. The position peaked at $860K in Q2 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • True Wealth Design reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • True Wealth Design sold 331 Hologic shares in Q2 2026, an estimated $25K.
  • True Wealth Design first reported a position in Hologic in Q4 2022 and held it in 14 quarters.
  • True Wealth Design's Hologic position peaked at $860K in Q2 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.